2013 - CTS 2013 Congress
Oral Communications 3
8.3 - Circulating miR-375 levels after islet transplantation in humans: a biomarker of ongoing beta cell injury
Presenter: Lorenzo, Piemonti, Milan, Italy
Authors: Lorenzo Piemonti1,2, Miguel Correa-Tapia 1,2, Vito Lampasona1,2, Jorge Ferrer1,2
Circulating miR-375 levels after islet transplantation in humans: a biomarker of ongoing beta cell injury
Lorenzo Piemonti1,2, Miguel Correa-Tapia 1,2, Vito Lampasona1,2, Jorge Ferrer1,2
1Diabetes Research Institute (OSR-DRI), San Raffaele Scientific Institute, Milan, Italy; 2Genomic Programming of Beta-cells Laboratory, Institut d'Investigacions August Pi i Sunyer (IDIBAPS); CIBER de Diabetes y Enfermedades MetabÃ³licas Asociadas (CIBERDEM), Barcellona, Spain
Conclusion.The results suggest that circulating miR-375 levels is a useful non-invasive indicator of ongoing beta cell injury after islet transplantation.
1. Erener, S. et al. Endocrinology 2013; 154:603
You must be logged in to view recordings
By viewing the material on this site you understand and accept that:
- The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
- The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
- The material is solely for educational purposes for qualified health care professionals.
- The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
- The information cannot be used as a substitute for professional care.
- The information does not represent a standard of care.
- No physician-patient relationship is being established.